Procyrion Receives FDA Breakthrough Device Designation for Aortix™ System
Houston, TX (July 30, 2019) – Procyrion, Inc., a medical device company developing percutaneous circulatory support devices for the treatment of heart failure, announced today that it has secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its Aortix™ System. Aortix is a circulatory support device for chronic heart failure patients […]
Procyrion Receives FDA Breakthrough Device Designation for Aortix™ System Read More »